Radiotherapy in combination with mTOR inhibition (temsirolimus) is an alternative schedule that has proved efficient in preclinical studies [62] and is currently under evaluation in a clinical study of newly diagnosed glioblastomas in comparison to chemoirradiation and lack of MGMT methylation [63]. This evidence concerns the gene MTOR and glioblastoma.